BNP PARIBAS FINANCIAL MARKETS - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 23 filers reported holding OBALON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$263,000
-48.5%
376
+5.9%
0.00%
Q1 2019$511,000
-30.5%
3550.0%0.00%
Q4 2018$735,000
-23.3%
3550.0%0.00%
Q3 2018$958,000
+25.6%
3550.0%0.00%
Q2 2018$763,000
-89.4%
355
-83.0%
0.00%
Q1 2018$7,165,000
-38.8%
2,089
+18.0%
0.00%
Q4 2017$11,706,000
+123.3%
1,771
+222.0%
0.00%
Q3 2017$5,242,000
-18.0%
550
-14.7%
0.00%
Q2 2017$6,392,000
+572.1%
645
+624.7%
0.00%
Q1 2017$951,000890.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$16,217,0005.54%
Tamarack Advisers, LP 604,036$3,993,0002.18%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$2,184,0000.17%
Moisand Fitzgerald Tamayo, LLC 6,677$288,0000.17%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 446,284$2,950,0000.12%
FORMULA GROWTH LTD 108,998$720,0000.10%
Granite Investment Partners, LLC 108,758$719,0000.04%
TIVERTON ASSET MANAGEMENT LLC 103,036$681,0000.04%
Bellevue Group AG 48,000$317,0000.03%
C WorldWide Group Holding A/S 276,211$1,826,0000.03%
View complete list of OBALON THERAPEUTICS INC shareholders